Abnova Taiwan Corp
TWSE:4133

Watchlist Manager
Abnova Taiwan Corp Logo
Abnova Taiwan Corp
TWSE:4133
Watchlist
Price: 23.7 TWD -1.04% Market Closed
Market Cap: NT$1.4B

Operating Margin

4.3%
Current
Declining
by 7%
vs 3-y average of 11.4%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
4.3%
=
Operating Income
NT$15.4m
/
Revenue
NT$355.1m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
4.3%
=
Operating Income
NT$15.4m
/
Revenue
NT$355.1m

Peer Comparison

Country Company Market Cap Operating
Margin
TW
Abnova Taiwan Corp
TWSE:4133
1.4B TWD
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
236.9B USD
Loading...
US
Danaher Corp
NYSE:DHR
165.5B USD
Loading...
CH
Lonza Group AG
SIX:LONN
37.6B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.1B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
279.2B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
38.2B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
28.8B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.3B EUR
Loading...

Market Distribution

In line with most companies in Taiwan
Percentile
47th
Based on 1 045 companies
47th percentile
4.3%
Low
-21 347.1% — 0.7%
Typical Range
0.7% — 11.5%
High
11.5% — 698%
Distribution Statistics
Taiwan
Min -21 347.1%
30th Percentile 0.7%
Median 5%
70th Percentile 11.5%
Max 698%

Abnova Taiwan Corp
Glance View

Abnova Taiwan Corp. is engaged in researching, developing, manufacturing and selling antibodies. The company is headquartered in Taipei City, Taipei. The company went IPO on 2008-05-27. The firm's products mainly include monoclonal antibodies, polyclonal antibodies, protein fragments, full-length proteins, active proteins, antibody pairs, fluorescence in situ hybridization probe and others. The firm's monoclonal and polyclonal antibodies are primarily applied in medical testing reagents, agricultural testing, industrial purification, medical treatment and other fields. Its proteins are mainly applied in medical testing reagents, agricultural testing, medical treatment, protein engineering and other fields. Its products are mainly traded in Taiwan, Americas and Europe.

Abnova Taiwan Corp Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
4.3%
=
Operating Income
NT$15.4m
/
Revenue
NT$355.1m
What is Abnova Taiwan Corp's current Operating Margin?

The current Operating Margin for Abnova Taiwan Corp is 4.3%, which is below its 3-year median of 11.4%.

How has Operating Margin changed over time?

Over the last 3 years, Abnova Taiwan Corp’s Operating Margin has decreased from 11.8% to 4.3%. During this period, it reached a low of 4.3% on Oct 30, 2025 and a high of 16.1% on Mar 31, 2023.

Back to Top